Form 4 for DH Definitive Healthcare Corp.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001209191-23-011189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | 2023-02-16 | DH | Mirisola Joseph Gianni | Chief Revenue Off | A - Grant | $0.00 | +136.6K | 188.4K | +264% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-16 | A | A | 136,640 | $0.00 | 188,363 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001. The RSUs vest over a four-year period, with 25% of the RSUs vesting on February 1, 2024, followed by quarterly vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date. |